权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

The natural killer cell response against mouse cytomegalovirus infection

自然杀伤细胞对小鼠巨细胞病毒感染的反应

基本信息

批准号：
10189486
负责人：
Joseph Chai-Yuen Sun
金额：
$ 53.3万
依托单位：
SLOAN-KETTERING INST CAN RESEARCH
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
起止时间：
2012-06-18 至 2022-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10189486
关键词：
ATG3 gene Activated Natural Killer Cell Address Antiviral Agents Antiviral Response Apoptosis Autophagocytosis BNIP3L gene Binding Binding Sites Biological Biology Cancer Patient Cell Compartmentation Cell Cycle Cell Survival Cells Clinical Clonal Expansion Communicable Diseases Cytomegalovirus Cytomegalovirus Infections DNA Binding DNA Binding Domain DNA sequencing Data Defect Development Disease Effector Cell Epigenetic Process Exhibits Family Family member Funding Gene Targeting Generations Genes Genetic Transcription Goals Grant Growth Health Helix-Turn-Helix Motifs High-Throughput RNA Sequencing Host Defense Human IFN consensus sequence binding protein IRF1 gene Immune Immune system Immunization Immunocompromised Host Immunologic Memory Immunoprecipitation Individual Infection Inflammatory Innate Immune System Interleukin-12 Investigation Knockout Mice Lead Life Lymphocyte Mass Spectrum Analysis Measures Mediating Memory Metabolic Metabolism Mitochondria Modeling Molecular Monkeys Murid herpesvirus 1 Mus Natural Killer Cells Newborn Infant Pathway interactions Pattern Phase Play Process Proteomics Reporter Rest Role STAT4 gene STAT4 protein System Testing Therapeutic Transcription Factor AP-1 Transcriptional Regulation Transgenic Mice Transgenic Organisms Transplant Recipients United States National Institutes of Health Virus Virus Diseases Winged Helix arm base chromatin immunoprecipitation comparative conditional knockout cytokine epigenetic profiling experimental study genomic locus member memory recall novel pathogen programs response transcription factor transcriptome transcriptomics

项目摘要

Project Summary Natural killer (NK) cells constitute an important arm of the host immune system that detects and eliminates virus-infected cells. Newborns and immunocompromised patients lack NK cells and are extremely susceptible to viral infection, and in particular, human cytomegalovirus (HCMV) can cause severe health complications or be life-threatening in these individuals. Mouse cytomegalovirus (MCMV) is an accurate and robust model for HCMV infection, and represents a good system to study antiviral NK cell responses. Using MCMV infection in mice, we have discovered that NK cells possess novel adaptive immune features such as clonal expansion and long-lived memory. From the funding in the initial R01 period, our lab has uncovered many of the cellular and molecular mechanisms underlying NK cell memory. Our long-term goals are to understand the general biology of NK cells and the molecular basis by which these powerful effector cells can mediate protection against pathogen invasion. To this end, we have recently identified a novel role for the transcription factor IRF8 in the NK cell response against MCMV infection. Based on this exciting preliminary data, our current R01 renewal proposes to use a newly-generated transgenic mouse where Irf8 is specifically ablated in NK cells to study the impact of this transcription factor in antiviral responses. In Aim 1, we will perform epigenetic profiling of activated NK cells to determine how IRF8-mediated NK cell expansion and effector function are controlled following MCMV infection. In Aim 2, we will identify the binding partners and gene targets of IRF8 in antiviral NK cells using proteomic and transcriptomic analyses, respectively. In Aim 3, we will measure mitochondrial health and metabolism in antiviral NK cells to investigate the mechanisms behind IRF8-mediated survival of effector and memory NK cells during the contraction phase following MCMV clearance. Together, the studies in this R01 renewal will not only advance our understanding of the transcriptional mechanisms whereby NK cells contribute to host defense during viral infection, but also establish novel clinical paradigms for how the NK cell compartment may be harnessed for immunization and therapeutic strategies against infectious disease.

项目总结